Written questions by Obese-Jecty.

Innovation and Technology, what progress has she made in adopting the sovereign Satellite Based Augmentation System (UK SBAS).

Awaiting answer.

Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on

Awaiting answer.

Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on

Awaiting answer.

Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on

Awaiting answer.

Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on

Awaiting answer.

Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on

Awaiting answer.

Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on

Awaiting answer.

Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on

Awaiting answer.

Innovation and Technology, with reference to the fourth report of the Joint Committee on the National Security Strategy (CP1338), published on 24 June 2025, what progress has he made in bringing new creativity to UK international partnerships in technology.

Awaiting answer.

Innovation and Technology, pursuant to the answer of 16 April 2026 to question 126825 on Animal Experiments, by what date in 2026 does she plan to publish a delivery update.

Awaiting answer.

Innovation and Technology, with reference to the Answer of 16 April 2026 to question 126825 on Animal Experiments, with which countries is she currently scoping opportunities for international engagement at a) multilateral and b) bilateral level.

Awaiting answer.

Innovation and Technology, pursuant to the answer of 16 April 2026 to question 126825 on Animal Experiments, what progress has she made regarding reform of the Medicines and Healthcare products Regulatory Agency.

Awaiting answer.

Innovation and Technology, which projects are being delivered by the Advanced Research and Invention Agency.

Awaiting answer.

Innovation and Technology, what is the scope of Project REFLECT under the Advanced Research and Invention Agency.

Awaiting answer.

Innovation and Technology, with reference to the policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made on applying only validated alternative methods for pharmacopoeial pyrogen testing.

Rabbit pyrogen tests were removed from the British Pharmacopeia in 2025 under this Government, meaning that no rabbit pyrogenicity testing should now be conducted in the UK for any pharmacopoeial pyrogen testing purposes. International (ISO) standards for medical devices may require the use of rabbit pyrogen testing for market authorisation for non-UK markets. Where this is the case Prospective Authorisation would need to be granted by the Home Office, no such tests were carried out in 2025. We are working with the Home Office to ensure that no new licences are approved that include the use of the rabbit pyrogen tests where validated alternatives are available.

Innovation and Technology, with reference to the policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made on replacing the rabbit pyrogen test.

Rabbit pyrogen tests were removed from the British Pharmacopeia in 2025 under this Government, meaning that no rabbit pyrogenicity testing should now be conducted in the UK for any pharmacopoeial pyrogen testing purposes. International (ISO) standards for medical devices may require the use of rabbit pyrogen testing for market authorisation for non-UK markets. Where this is the case Prospective Authorisation would need to be granted by the Home Office, no such tests were carried out in 2025. We are working with the Home Office to ensure that no new licences are approved that include the use of the rabbit pyrogen tests where validated alternatives are available.

Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made in obtaining the full validation of the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative to predict the proarrhythmic potential of new drugs.

The strategy has not committed to obtaining the full validation of the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative to predict the proarrhythmic potential of new drugs.Basket 2 of the strategy outlines long‑term ambitions which must be science‑led, partnership‑based, and delivered over time.The strategy aims to use validated alternative methods to reduce the use of dogs and non-human primates in dedicated Pharmacokinetic studies for human medicines by at least 35% by 2030.

Innovation and Technology, with reference to the policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made on working with regulatory agencies to accelerate the replacement of the Rabbit Pyrogen Test with the Monocyte Activation Test across UK guidelines.

Rabbit pyrogen tests were removed from the British Pharmacopeia in 2025 under this Government, meaning that no rabbit pyrogenicity testing should now be conducted in the UK for any pharmacopoeial pyrogen testing purposes. International (ISO) standards for medical devices may require the use of rabbit pyrogen testing for market authorisation for non-UK markets. Where this is the case Prospective Authorisation would need to be granted by the Home Office, no such tests were carried out in 2025. We are working with the Home Office to ensure that no new licences are approved that include the use of the rabbit pyrogen tests where validated alternatives are available.

Innovation and Technology, with reference to the policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made on restarting the survey on public attitudes to animal research.

A competition has been launched to secure support in delivering the next waves of the survey on public attitudes to animal research. Feedback from key stakeholders has been sought on the survey questions from the last wave.

Innovation and Technology, with reference to the policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made on establishing the Alternative Methods Strategy Delivery Group.

The Alternative Methods Strategy Delivery Group first met on 24 February 2026, and its next meeting is scheduled for 28 April 2026.